Efficacy Study of High Dose Symlin to Treat Type 2 Diabetes Mellitus
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01137695|
Recruitment Status : Unknown
Verified October 2011 by Cheryl Rosenfeld, DO, North Jersey Endocrine Consultants, LLC.
Recruitment status was: Active, not recruiting
First Posted : June 4, 2010
Last Update Posted : October 14, 2011
Cheryl Rosenfeld, DO
Amylin Pharmaceuticals, LLC.
Information provided by (Responsible Party):
Cheryl Rosenfeld, DO, North Jersey Endocrine Consultants, LLC
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||January 2012|
|Estimated Study Completion Date :||April 2012|